Clincosm LogoSign in Get a demo

Mar-Kid: Frailty Assessment Among Kidney Transplant Candidates

Sponsor
Parc de Salut Mar (Other)
Overall Status
Completed
CT.gov ID
NCT04811417
Collaborator
(none)
500
Enrollment
61
Actual Duration (Months)

Study Details

Study Description

Brief Summary

Frailty is common among chronic kidney disease patients who are on the kidney transplant (KT) waiting list.

The aim of this study is to assess frailty according to different frailty tools among KT candidates and to establish potential biomarkers of frailty.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is an observational study where KT candidates will be assessed for frailty according to:

    • Frailty Fried Phenotype and

    • FRAIL scale

    Sociodemographics and clinical variables will be collected and serum samples will be obtained in order to implement further studies regarding biomarkers of frailty..

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Frailty Assessment Among Kidney Transplant Candidates on the Waiting List
    Actual Study Start Date :
    Jun 1, 2015
    Actual Primary Completion Date :
    Jun 30, 2020
    Actual Study Completion Date :
    Jun 30, 2020

    Outcome Measures

    Primary Outcome Measures

    1. Prevalence of frailty among KT candidates [2015-2020]

      Prevalence of frailty according FRIED and FRAIL scale

    2. Biomarkers of frailty among KT candidates [2015-2020]

      Serum samples for biomarkers

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • KT candidates accepted for the KT waiting list
    Exclusion Criteria:

    • No willing for participating

    • Difficulty in understanding Spanish or English

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Parc de Salut Mar

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    M José Pérez Sáez, Principal Investigator, Parc de Salut Mar
    ClinicalTrials.gov Identifier:
    NCT04811417
    Other Study ID Numbers:
    • 2018/7798/I
    First Posted:
    Mar 23, 2021
    Last Update Posted:
    Sep 22, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Frailty

    Study Results

    No Results Posted as of Sep 22, 2021